Relationship between clinical and histologic findings with tulisokibart induction at Week 12 and maintenance dosing at Week 50 in the Phase 2 Randomized Controlled ARTEMIS-UC Study in participants with ulcerative colitis

Brigid S. Boland; Christopher Ma; Rupert W. Leong; Jaroslaw Leszczyszyn; Xavier Hebuterne; Jin Xu; Wen Zhou; Mark Yen

doi:10.14309/01.ajg.0001133264.38635.b8

Relationship between clinical and histologic findings with tulisokibart induction at Week 12 and maintenance dosing at Week 50 in the Phase 2 Randomized Controlled ARTEMIS-UC Study in participants with ulcerative colitis

Brigid S. Boland, Christopher Ma, Rupert W. Leong, Jaroslaw Leszczyszyn, Xavier Hebuterne, Jin Xu, Wen Zhou, Mark Yen

Macquarie Medical School

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	S1451
Pages (from-to)	S312
Number of pages	1
Journal	American Journal of Gastroenterology
Volume	120
Issue number	10 S2
DOIs	https://doi.org/10.14309/01.ajg.0001133264.38635.b8
Publication status	Published - Oct 2025
Event	2025 American College of Gastroenterology Annual Meeting: ACG 2025 - Phoenix, United States Duration: 24 Oct 2025 → 29 Oct 2025

Access to Document

10.14309/01.ajg.0001133264.38635.b8

Cite this

Boland, B. S., Ma, C., Leong, R. W., Leszczyszyn, J., Hebuterne, X., Xu, J., Zhou, W., & Yen, M. (2025). Relationship between clinical and histologic findings with tulisokibart induction at Week 12 and maintenance dosing at Week 50 in the Phase 2 Randomized Controlled ARTEMIS-UC Study in participants with ulcerative colitis. American Journal of Gastroenterology, 120(10 S2), S312. Article S1451. https://doi.org/10.14309/01.ajg.0001133264.38635.b8

@article{e77e61950e654d189b6abdc1846047bf,

title = "Relationship between clinical and histologic findings with tulisokibart induction at Week 12 and maintenance dosing at Week 50 in the Phase 2 Randomized Controlled ARTEMIS-UC Study in participants with ulcerative colitis",

author = "Boland, {Brigid S.} and Christopher Ma and Leong, {Rupert W.} and Jaroslaw Leszczyszyn and Xavier Hebuterne and Jin Xu and Wen Zhou and Mark Yen",

year = "2025",

month = oct,

doi = "10.14309/01.ajg.0001133264.38635.b8",

language = "English",

volume = "120",

pages = "S312",

journal = "American Journal of Gastroenterology",

issn = "0002-9270",

publisher = "Wolters Kluwer Health",

number = "10 S2",

note = "2025 American College of Gastroenterology Annual Meeting : ACG 2025 ; Conference date: 24-10-2025 Through 29-10-2025",

}

Boland, BS, Ma, C, Leong, RW, Leszczyszyn, J, Hebuterne, X, Xu, J, Zhou, W & Yen, M 2025, 'Relationship between clinical and histologic findings with tulisokibart induction at Week 12 and maintenance dosing at Week 50 in the Phase 2 Randomized Controlled ARTEMIS-UC Study in participants with ulcerative colitis', American Journal of Gastroenterology, vol. 120, no. 10 S2, S1451, pp. S312. https://doi.org/10.14309/01.ajg.0001133264.38635.b8

Relationship between clinical and histologic findings with tulisokibart induction at Week 12 and maintenance dosing at Week 50 in the Phase 2 Randomized Controlled ARTEMIS-UC Study in participants with ulcerative colitis. / Boland, Brigid S.; Ma, Christopher; Leong, Rupert W. et al.
In: American Journal of Gastroenterology, Vol. 120, No. 10 S2, S1451, 10.2025, p. S312.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Relationship between clinical and histologic findings with tulisokibart induction at Week 12 and maintenance dosing at Week 50 in the Phase 2 Randomized Controlled ARTEMIS-UC Study in participants with ulcerative colitis

AU - Boland, Brigid S.

AU - Ma, Christopher

AU - Leong, Rupert W.

AU - Leszczyszyn, Jaroslaw

AU - Hebuterne, Xavier

AU - Xu, Jin

AU - Zhou, Wen

AU - Yen, Mark

PY - 2025/10

Y1 - 2025/10

U2 - 10.14309/01.ajg.0001133264.38635.b8

DO - 10.14309/01.ajg.0001133264.38635.b8

M3 - Meeting abstract

SN - 0002-9270

VL - 120

SP - S312

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

IS - 10 S2

M1 - S1451

T2 - 2025 American College of Gastroenterology Annual Meeting

Y2 - 24 October 2025 through 29 October 2025

ER -

Boland BS, Ma C, Leong RW, Leszczyszyn J, Hebuterne X, Xu J et al. Relationship between clinical and histologic findings with tulisokibart induction at Week 12 and maintenance dosing at Week 50 in the Phase 2 Randomized Controlled ARTEMIS-UC Study in participants with ulcerative colitis. American Journal of Gastroenterology. 2025 Oct;120(10 S2):S312. S1451. doi: 10.14309/01.ajg.0001133264.38635.b8